InvestorsHub Logo
Followers 0
Posts 240
Boards Moderated 0
Alias Born 10/20/2009

Re: Loonley Tunes post# 1649

Wednesday, 06/09/2010 2:51:06 PM

Wednesday, June 09, 2010 2:51:06 PM

Post# of 8138
Something for a future positive view:

From their last 10Q ( http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6974288 )on page 14 and 15:

Plan of Operation

The Company plans on becoming a significant transdisciplinary biomedical/biotechnology company involved in the discovery, development, acquisition and commercialization of a broad range of biotechnology, and biomedical technologies as well as nutraceutical and molecular diagnostic technologies to improve human health.

We intend to develop, manufacture and sell directly or indirectly through collaborative partners, the following types of products:

PRODUCT/R&D PHASE/DESCRIPTION
VivaThermic Vials / Phase III / Centrifugable and autoclavable vials for cryopreservation

Cryopsy / Phase I / Device that rapidly freezes tissue specimens

VivaSight / Phase II / Digital PhotoRefractor for children's vision screening

VivAuris / Phase II / nDevice for middle ear redness detection

VivaGlobin / Phase II / Device for anemia and Cutaneous hemoglobin detection

VivaBoost / Phase III / Phytochemical rich daily dose nutraceutical beverage

VivaBlend / Phase III / Concentrated phytochemical/ antioxidant extract supplement

VivaGastroProtect / Phase I / Fruits and vegetables extract for the protection of digestive system

VivaCrop /Phase I / Vegetation health monitor

Clinical Sensor (CBS)/ Phase I / In vitro diagnostic device used at the point of care

SLICES / Phase II /MRI enhancement software

We also plan to continue to offer contract research and development services in molecular biology, device engineering and other areas. We commenced providing contract research and development services in the first quarter of 2008. During the first quarter 2009, we commenced sales of our VivaThermic vials and we commenced sales of VivaBlend in the second quarter of 2009. In December 2009, we entered into a license agreement with Regeneca International, Inc. (“Regeneca”) for VivaBoost whereby Regeneca obtained exclusive worldwide distribution rights in the direct-to-consumer market and has committed to purchase $5,000,000 of product over a thirty-six month period. ....


Looks like they have a lot of products in the development phase. in other way VIVK remind me MMRF who had a lot of positive news and was flat at 0.06 for lot of time(Link to 1 year chart http://stockcharts.com/h-sc/ui?s=MMRF&p=D&yr=1&mn=0&dy=0&id=p27722707303 )

Good luck

Loonley Tunes

Before you buy something do a good DD and make your own conclusions. My post express only my oppinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VIVK News